The Asian Pediatric Hematology and Oncology Group (APHOG) and SIOP Asia invite you to the 6th APHOG & SIOP Asia Joint Scientific Symposium. This year’s online session is about germ cell tumours in children and adolescents. Experts from across the region will share real-world experience and discuss de-escalation, stem cell transplantation and treatment for relapsed and refractory disease.
Date: Wednesday, 4 November 2026
Time:
- 06:00–08:00 EST (USA)
- 12:00–14:00 CET (Europe)
- 16:30–18:30 IST (India)
- 20:00–22:00 JST (Japan)
Format: Online webinar
Programme
Opening Remarks
- Akira Nakagawara, Chairman, Executive Council, APHOG
- Gevorg Tamamyan, President, SIOP Asia; APHOG
Moderators
- Godfrey Chan (Hong Kong, China; SIOP & APHOG)
- Rashmi Dalvi (India; SIOP & APHOG)
- Ruzanna Papyan (Armenia; POEM, SIOP & APHOG)
Presentations
- “Less is More: When Is De-escalation Safe in Pediatric Germ Cell Tumors?”
Raphah Borghol, Children’s Cancer Institute, AUBMC, Beirut, Lebanon - “Germ Cell Tumors in India: Real World Experience and the MAGIC Trial”
Girish Chinnaswamy, Tata Memorial Hospital, INPHOG, India - “Hematopoietic Stem Cell Transplantation for Children with Germ Cell Tumor”
Kirill Kirgizov, RSPOH, Russia - “What Is the Optimal Treatment Strategy for Relapsed or Refractory Pediatric and Adolescent Extracranial Germ Cell Tumors?”
Yuki Arakawa, Saitama Children’s Medical Center, JCCG, Japan
Closing Remarks
- Hiroki Hori, Immediate Past-President, SIOP Asia
